
Genetic Technologies Limited GENE
Annual report 2022
added 08-30-2022
Genetic Technologies Limited DSO Ratio 2011-2026 | GENE
Annual DSO Ratio Genetic Technologies Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 11.7 K | 581 | 300 | 279 | 130 | 88.9 | 35.5 | 49 | 13.5 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.7 K | 13.5 | 1.47 K |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Medpace Holdings
MEDP
|
50.4 | $ 460.74 | 0.83 % | $ 13.3 B | ||
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
82.1 | $ 9.15 | 1.67 % | $ 610 M | ||
|
Biodesix
BDSX
|
41.7 | $ 15.54 | 5.79 % | $ 2.02 B | ||
|
Myriad Genetics
MYGN
|
52.3 | $ 4.61 | -1.07 % | $ 427 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.44 | -0.4 % | $ 390 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
101 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Pacific Biosciences of California
PACB
|
71.8 | $ 1.39 | - | $ 417 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 159.19 | 0.75 % | $ 7.89 B | ||
|
IQVIA Holdings
IQV
|
73.9 | $ 166.09 | -0.52 % | $ 28.6 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Personalis
PSNL
|
55.8 | $ 7.78 | 2.23 % | $ 461 M | ||
|
Invitae Corporation
NVTA
|
242 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
63.7 | $ 1.18 | -19.18 % | $ 6.43 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 264.46 | 1.94 % | $ 26.1 B | ||
|
Interpace Biosciences
IDXG
|
53.1 | $ 1.71 | 0.73 % | $ 7.5 M | ||
|
Illumina
ILMN
|
61.3 | $ 125.98 | 1.77 % | $ 20 B | ||
|
RadNet
RDNT
|
34.5 | $ 59.87 | -3.03 % | $ 4.5 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
Precipio
PRPO
|
28.1 | $ 26.6 | -1.23 % | $ 34.5 M | ||
|
Senseonics Holdings
SENS
|
10.3 | $ 6.66 | 0.6 % | $ 278 M | ||
|
Sotera Health Company
SHC
|
43.9 | $ 13.84 | -0.32 % | $ 3.93 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 266.12 | 0.64 % | $ 22.1 B | ||
|
Soleno Therapeutics
SLNO
|
27 | $ 31.34 | -1.2 % | $ 1.59 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 3.46 | -0.57 % | $ 1.86 M | ||
|
NeoGenomics
NEO
|
77.7 | $ 7.86 | -2.96 % | $ 1.01 B | ||
|
Neuronetics
STIM
|
48.7 | $ 1.46 | -9.06 % | $ 96.3 M | ||
|
Natera
NTRA
|
81.5 | $ 194.52 | -2.78 % | $ 19.1 B | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.84 | 1.59 % | $ 951 M | ||
|
OPKO Health
OPK
|
240 | $ 1.13 | -1.74 % | $ 784 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 25.35 | -1.55 % | $ 704 M | ||
|
DarioHealth Corp.
DRIO
|
56.7 | $ 7.76 | 3.47 % | $ 30.9 M | ||
|
DexCom
DXCM
|
87 | $ 66.6 | 1.0 % | $ 26 B | ||
|
Exact Sciences Corporation
EXAS
|
30.8 | $ 104.91 | - | $ 19.8 B | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 47.49 | 6.72 % | $ 2.84 B |